back to overview


The digital healthtech sector is expanding – and so are we!

April 07, 2020 + Jessica Di Palo
3 Min read

MTIP welcomes in April Christoph Mårtensson as Investment Associate and Jessica Di Palo as Head of Marketing and Communications!

In the midst of the Covid-19 crisis, the healthcare industry is experiencing an unprecedented boom. We at MTIP are also currently experiencing a peak, as we had the honour of welcoming two new employees in April. One is Christoph Mårtensson, who is starting as an Investment Associate, and the other is Jessica Di Palo, who will take on the new role as Head of Marketing and Communications.

Christoph Mårtensson has a scientific background in biochemistry and molecular biology. He received his Ph.D. with distinction from the University of Freiburg, Germany. During his academic years, he published several research projects in high-impact journals such as Nature and Cell. He studied Molecular Life Science at the University of Lübeck and spent a semester abroad at Imperial College London. His studies will allow him a very distinctive point of view on his day to day work, especially in evaluating interesting investment opportunities.

Portrait Dr. Christoph Martensson

While studying communications at the University of Zurich, Jessica Di Palo began her career at the advertising agency TBWA\Switzerland. During her master’s degree she gained a lot of experience in marketing and sales at Basler Versicherungen AG. After her graduation she learned everything about digital marketing at the digital agency Mind Studios from where she switched again to marketing at UVEX Arbeitsschutz (Schweiz) AG. With a passion for marketing and communication, she joins MTIP to work with its world class international team to amplify their vision to create true long-term value in key markets around the world.

Jessica Di Palo Portrait

We are very excited that Christoph Mårtensson and Jessica Di Palo will be joining us for our mission “Empower innovation that improves lives“.

Share the Article


Diversity, Equity, and Inclusion: The 3 Key Drivers for Success

We have talked with Caroline Noublanche, CEO of our portfolio company Apricity, about her company’s DEI efforts.


Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

Growth Capital Decisions


Rahel Hafner Receives Certificate in ESG Investing by CFA Institute

Rahel Hafner Receives Certificate in ESG Investing


What Makes a Great Founder/Investor Relationship?

Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva


MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".


Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022


MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment


MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium


Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development


The psychology of decision making

What makes a good investor?


Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage


MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!


Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!


MTIP invests in Mediktor

New investment in Mediktor


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health